INHIBITION OF NORFLOXACIN ABSORPTION BY DAIRY-PRODUCTS

被引:36
作者
KIVISTO, KT
OJALAKARLSSON, P
NEUVONEN, PJ
机构
关键词
D O I
10.1128/AAC.36.2.489
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Seven healthy subjects received, after an overnight fast, a single 200-mg oral dose of norfloxacin with water, whole milk, and unflavored yoghurt. Coadministration of milk or yoghurt reduced the extent of norfloxacin absorption and the mean peak concentration in plasma by approximately 50%. Taking of norfloxacin with these liquid dairy products should be avoided.
引用
收藏
页码:489 / 491
页数:3
相关论文
共 15 条
[1]  
FROST RW, 1989, CLIN PHARMACOL THER, V45, P165
[2]   CIPROFLOXACIN PHARMACOKINETICS AFTER A STANDARD OR HIGH-FAT HIGH-CALCIUM BREAKFAST [J].
FROST, RW ;
CARLSON, JD ;
DIETZ, AJ ;
HEYD, A ;
LETTIERI, JT .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (10) :953-955
[3]   A SIMPLE ISOCRATIC HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ASSAY OF QUINOLONES IN SERUM [J].
GRIGGS, DJ ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (03) :437-445
[4]   NORFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
HOLMES, B ;
BROGDEN, RN ;
RICHARDS, DM .
DRUGS, 1985, 30 (06) :482-513
[5]  
HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606
[6]   OFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
MONK, JP ;
CAMPOLIRICHARDS, DM .
DRUGS, 1987, 33 (04) :346-391
[7]   THE CLINICAL-SIGNIFICANCE OF FOOD-DRUG INTERACTIONS - A REVIEW [J].
NEUVONEN, PJ ;
KIVISTO, KT .
MEDICAL JOURNAL OF AUSTRALIA, 1989, 150 (01) :36-40
[8]   INTERACTIONS WITH ABSORPTION OF TETRACYCLINES [J].
NEUVONEN, PJ .
DRUGS, 1976, 11 (01) :45-54
[9]   INTERFERENCE OF DAIRY-PRODUCTS WITH THE ABSORPTION OF CIPROFLOXACIN [J].
NEUVONEN, PJ ;
KIVISTO, KT ;
LEHTO, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) :498-502
[10]   EFFECTS OF ALUMINUM AND MAGNESIUM ANTACIDS AND RANITIDINE ON THE ABSORPTION OF CIPROFLOXACIN [J].
NIX, DE ;
WATSON, WA ;
LENER, ME ;
FROST, RW ;
KROL, G ;
GOLDSTEIN, H ;
LETTIERI, J ;
SCHENTAG, JJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (06) :700-705